Leerink Swann Downgrades The Medicines Company (MDCO) to Market Perform
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Join SI Premium – FREE
Leerink Swann downgraded The Medicines Company (NASDAQ: MDCO) from Outperform to Market Perform with a price target of $27.00 (from $30.00).
For an analyst ratings summary and ratings history on The Medicines Company click here. For more ratings news on The Medicines Company click here.
Shares of The Medicines Company closed at $24.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades ULTA Salon (ULTA) to Hold, 'Competition Intensifying & Prestige Refresh Needed'
- Morgan Stanley Upgrades Shopify (SHOP) to Overweight, 'Still Operating Leverage Left to Realize'
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,680 at HSBC
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
